Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Epidemiology and pathogenesis of influenza.

Zambon MC.

J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9. Review.

PMID:
10877456
2.

Recent zoonoses caused by influenza A viruses.

Alexander DJ, Brown IH.

Rev Sci Tech. 2000 Apr;19(1):197-225. Review.

PMID:
11189716
3.

Zanamivir: a rational approach to influenza B.

Penn CR, Osterhaus A.

Scand J Infect Dis. 2001;33(1):33-40. Review.

PMID:
11234975
4.

The pathogenesis of influenza in humans.

Zambon MC.

Rev Med Virol. 2001 Jul-Aug;11(4):227-41. Review.

PMID:
11479929
6.

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.

Hilleman MR.

Vaccine. 2002 Aug 19;20(25-26):3068-87. Review.

PMID:
12163258
7.

Molecular anatomy of 2009 influenza virus A (H1N1).

Arias CF, Escalera-Zamudio M, Soto-Del Río Mde L, Cobián-Güemes AG, Isa P, López S.

Arch Med Res. 2009 Nov;40(8):643-54. doi: 10.1016/j.arcmed.2009.10.007. Review.

PMID:
20304251
8.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
10.

The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.

Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A.

J Virol. 2000 Dec;74(23):11108-14.

11.

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.

Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, Ito Y, Tashiro M, Suzuki Y.

Virol J. 2009 Aug 13;6:124. doi: 10.1186/1743-422X-6-124.

13.

A novel approach to antiviral therapy for influenza.

Colman PM.

J Antimicrob Chemother. 1999 Nov;44 Suppl B:17-22. Review.

PMID:
10877458
14.

Neuraminidase inhibitors in patients with underlying airways disease.

Williamson JC, Pegram PS.

Am J Respir Med. 2002;1(2):85-90. Review.

PMID:
14720062
15.

Immunity to influenza.

Schild GC, Oxford JS, Virelizier JL.

Dev Biol Stand. 1975;28:253-72.

PMID:
47824
16.

Zanamivir: from drug design to the clinic.

Elliott M.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1885-93. Review.

17.

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

Blick TJ, Sahasrabudhe A, McDonald M, Owens IJ, Morley PJ, Fenton RJ, McKimm-Breschkin JL.

Virology. 1998 Jun 20;246(1):95-103.

18.
19.

A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.

Hurt AC, Barr IG, Komadina N, Hampson AW.

Virus Res. 2004 Jul;103(1-2):79-83.

PMID:
15163493
20.

Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.

Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y.

J Virol. 2000 Jun;74(11):5206-12.

Supplemental Content

Support Center